<h4>Background</h4>Hypertrophic cardiomyopathy (HCM) is frequently associated with mutations in cardiac myosin binding protein C (cMyBP-C; MYBPC3) and cMyBP-C haploinsufficiency. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.